CERA researchers have explored the potential of genetic analysis to transform how Fuchs’ endothelial corneal dystrophy is diagnosed and treated, with the hope of improving future outcomes for patients. Imagine if treatment for your eye condition was tailored to your individual genetic makeup, not what works for most patients. This is the potential of …
Single-cell RNA sequencing – a precision medicine approach to diagnosing and treating Fuchs’ Endothelial Corneal Dystrophy
Share.
